Veraxa Biotech AG Ordinary Shares (VRXA)

Veraxa Biotech AG Ordinary Shares (VRXA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $156M; returns 1 day -2.9%, 1 week -9.9%.

Veraxa Biotech AG is a clinical-stage biotechnology company specializing in the development of next-generation antibody-based cancer therapies.

Groups VRXA belongs to

• Biotechnology
• Recent IPOs
• Oncology
• Cancer Therapeutics
• Biopharmaceutical
• Clinical Stage
• Antibody-Drug Conjugates
• Bispecific Antibodies
• Clinical Stage Biotech
• Antibody Therapeutics
• Monoclonal Antibodies
• Hematologic Malignancies
• Life Sciences
• Healthcare
• Strategic Partnerships

VRXA financial model: income statement, cash flow and balance sheet